SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-000938
Filing Date
2024-01-09
Accepted
2024-01-09 09:17:33
Documents
17
Period of Report
2024-01-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20240108_8k.htm   iXBRL 8-K 27963
2 EXHIBIT 3.1 ex_613231.htm EX-3.1 6783
3 EXHIBIT 3.2 ex_613232.htm EX-3.2 161720
4 EXHIBIT 99.1 ex_613436.htm EX-99.1 16315
9 ex_613436img001.jpg GRAPHIC 3755
  Complete submission text file 0001437749-24-000938.txt   395053

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240109.xsd EX-101.SCH 3408
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240109_def.xml EX-101.DEF 11803
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240109_lab.xml EX-101.LAB 15847
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240109_pre.xml EX-101.PRE 12018
11 EXTRACTED XBRL INSTANCE DOCUMENT acrx20240108_8k_htm.xml XML 2646
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 24521931
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)